10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,338,877 | -46.5% | 34,767 | -21.1% | 0.00% | 0.0% |
| Q2 2023 | $2,501,611 | -32.5% | 44,089 | -39.0% | 0.00% | -50.0% |
| Q1 2023 | $3,708,743 | +118.0% | 72,267 | +78.2% | 0.00% | +100.0% |
| Q4 2022 | $1,701,045 | +46.4% | 40,559 | +51.1% | 0.00% | 0.0% |
| Q2 2022 | $1,162,000 | -89.6% | 26,840 | -82.4% | 0.00% | -87.5% |
| Q1 2022 | $11,180,000 | -42.5% | 152,534 | -17.7% | 0.01% | -33.3% |
| Q4 2021 | $19,429,000 | -30.9% | 185,373 | -4.0% | 0.01% | -40.0% |
| Q3 2021 | $28,108,000 | -25.2% | 193,079 | +0.6% | 0.02% | -23.1% |
| Q2 2021 | $37,592,000 | – | 191,969 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |